酒精使用障碍的戒断患者的神经认知恢复:有关因素的范围审查
Jeroen Staudt1,2, Tim Kok1, Hein A de Haan1,3
1Tactus Addiction Treatment, Deventer, the Netherlands.
Neuropsychiatric disease and treatment
|October 4, 2023
概括
酒精使用障碍 (AUD) 患者的神经认知恢复受到吸烟和大脑体积等因素的影响. 戒酒本身并不能保证康复,需要对其他促成因素进行更多研究.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 成 药物 药物 药物 药物
背景情况:
- 神经认知缺陷在酒精使用障碍 (AUD) 中很常见.
- 在戒断AUD患者中神经认知恢复的程度仍然不一致报告.
- 除了禁欲之外的因素可能会影响康复,导致各种结果.
研究的目的:
- 审查影响AUD戒断患者神经认知恢复的因素.
- 基于现有证据,分析各种因素对神经认知恢复的影响.
主要方法:
- 在PubMed (2000-2023) 的系统文献搜索.
- 包括长度人类研究在戒断成人AUD患者的神经认知恢复.
- 不包括横截面研究,不符合DSM标准的研究或具有混神经疾病的研究.
主要成果:
- 在31项研究中确定了16个因素.
- 在神经认知恢复和吸烟 (负) 和大脑体积变化之间发现了一致的关联.
- 没有观察到与饮酒量或教育水平有一致的关系.
结论:
- 吸烟会对AUD患者的神经认知恢复产生负面影响.
- 大脑体积的变化与神经认知恢复有关.
- 建议对不足研究的因素和不一致的发现进行进一步的纵向研究.
更多相关视频
05:12Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
Published on: June 23, 2023
929
08:05A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
Published on: January 5, 2018
9.8K
相关概念视频
CNS Depressants: Alcohol and Nicotine
235
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
235
Substance Use Disorders Affecting Sleep
188
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
188
Drug Abuse and Addiction: Pharmacological Phenomena
501
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
501
Classification of Illness
7.6K
The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
7.6K
Alzheimer's Disease: Overview
513
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
513
Alzheimer's Disease: Treatment
212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212
